文献速递药物不良反应与药物警戒

药师出院药物核对工具干预可预防伤害并节省成本

Prevented harm and cost avoidance with pharmacist intervention while utilizing a discharge medication reconciliation tool.
PubMed 文献 · Am J Health Syst Pharm · 2024-01-01

该回顾性研究分析了社区教学医院2021年1月药师发起的出院药物核对干预,共190次干预,估计避免成本46,958至231,032美元,其中高风险药物相关避免成本为33,920至147,203美元,结论认为针对性药师出院药物核对可避免显著成本和患者伤害。

要点

  • 药师出院药物核对干预190次,估计避免成本46,958至231,032美元。
  • 高风险药物相关避免成本为33,920至147,203美元。
  • 成本避免最高的三类高风险药物为胰岛素、抗血栓药和阿片类。

核心结论

  • 针对性药师出院药物核对及相关干预可避免显著成本和患者伤害。

研究设计与样本

  • 回顾性图表审查,纳入社区教学医院2021年1月药师发起且提供者接受的出院药物核对干预。

主要发现

  • 药师在2021年1月共干预190次,估计避免成本46,958至231,032美元。
  • 高风险药物相关避免成本为33,920至147,203美元。
  • 成本避免最高的三类高风险治疗类别为胰岛素(16,738-70,793美元)、抗血栓药(13,884-60,016美元)和阿片类(2,638-11,834美元)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to determine prevented harm and cost avoidance following pharmacist intervention utilizing a discharge medication reconciliation tool. METHODS: A retrospective chart review was conducted to identify patients with pharmacist-initiated, provider-accepted discharge medication reconciliation interventions completed at a community teaching hospital in January 2021. Investigators assigned the discrepancies targeted for intervention a National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) category, probability of harm, and calculated cost avoidance. The primary endpoint was the total cost avoidance associated with discharge medication reconciliation. RESULTS: Pharmacists intervened 190 times in January 2021, avoiding an estimated $46,958 to $231,032 in cost. High-risk medications were associated with $33,920 to $147,203 in cost avoidance. The 3 high-risk therapeutic classes associated with the highest cost avoidance were insulin ($16,738-$70,793), antithrombotics ($13,884-$60,016), and opioids ($2,638-$11,834). CONCLUSION: Targeted pharmacist discharge medication reconciliation and related interventions avoid significant cost and patient harm.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Hoffman AM, Walls JL, Prusch A, et al. Prevented harm and cost avoidance with pharmacist intervention while utilizing a discharge medication reconciliation tool. Am J Health Syst Pharm. 2024. PMID: 37813103. doi:10.1093/ajhp/zxad243

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。